Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for E2 molecular functions

PLoS Pathogens

Volumn 8, Issue 6, 2012, Pages

  Muller, Mandy ^a,b   Jacob, Yves ^a   Jones, Louis ^a   Weiss, Amélie ^c   Brino, Laurent ^c   Chantier, Thibault ^d   Lotteau, Vincent ^d   Favre, Michel ^a   Demeret, Caroline ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d University Lyon i   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN 20; CELL PROTEIN; CULLIN; PROTEIN BRD4; PROTEIN BTBD1; PROTEIN CLTA; PROTEIN CTLA; PROTEIN E2; PROTEIN FBX022; PROTEIN GGA1; PROTEIN MGA; PROTEIN MYST2; PROTEIN NMI; PROTEIN NRBP1; PROTEIN P53; PROTEIN RAB31P; PROTEIN RSF; PROTEIN SCYL1; PROTEIN SPOP; PROTEIN TBP; PROTEIN VPS52; PROTEOME; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IIB; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VIRUS PROTEIN; VIRUS RNA; ONCOPROTEIN;

APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA LIBRARY; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN PAPILLOMAVIRUS 1; HUMAN PAPILLOMAVIRUS 3; HUMAN PAPILLOMAVIRUS 32; HUMAN PAPILLOMAVIRUS 39; HUMAN PAPILLOMAVIRUS 5; HUMAN PAPILLOMAVIRUS 8; HUMAN PAPILLOMAVIRUS 9; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 6; INTRACELLULAR TRANSPORT; MAMMAL CELL; NONHUMAN; PHYLOGENY; PROTEIN EXPRESSION; RNA PROCESSING; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; UBIQUITINATION; VIRUS PATHOGENESIS; VIRUS VIRULENCE; WART VIRUS; YEAST; CELL LINE; GENETICS; HOST PARASITE INTERACTION; HUMAN; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MAMMALIA; PAPILLOMAVIRIDAE;

CELL LINE; GENOTYPE; HOST-PARASITE INTERACTIONS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84864057178     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002761     Document Type: Article

References (50)

1. zur Hausen H, (2009) Papillomaviruses in the causation of human cancers- a brief historical account. Virology 384: 260-265.
2. Biliris KA, Koumantakis E, Dokianakis DN, Sourvinos G, Spandidos DA, (2000) Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett 161: 83-88.
3. Wiley D, Masongsong E, (2006) Human papillomavirus: the burden of infection. Obstet Gynecol Surv 61: S3-14.
4. Lehoux M, D'Abramo CM, Archambault J, (2009) Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 12: 268-280.
5. Desaintes C, Demeret C, (1996) Control of papillomavirus DNA replication and transcription. Semin Cancer Biol 7: 339-347.
6. McBride AA, Oliveira JG, McPhillips MG, (2006) Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5: 1499-1502.
7. Blachon S, Bellanger S, Demeret C, Thierry F, (2005) nucleo-cytoplasmic shuttling of high-risk HPV E2 proteins induces apoptosis. J Biol Chem 280: 36088-36098.
8. Parish JL, Kowalczyk A, Chen HT, Roeder GE, Sessions R, et al. (2006) E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol 80: 4580-4590.
9. Bellanger S, Blachon S, Mechali F, Bonne-Andrea C, Thierry F, (2005) High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 4: 1608-1615.
10. Pfefferle R, Marcuzzi GP, Akgul B, Kasper HU, Schulze F, et al. (2008) The Human Papillomavirus Type 8 E2 Protein Induces Skin Tumors in Transgenic Mice. J Invest Dermatol 10: 10.
11. Bellanger S, Tan CL, Xue YZ, Teissier S, Thierry F, (2011) Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Am J Cancer Res 1: 373-389.
12. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, (2004) Classification of papillomaviruses. Virology 324: 17-27.
13. Navratil V, de Chassey B, Meyniel L, Delmotte S, Gautier C, et al. (2009) VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks. Nucleic Acids Res 37: D661-668.
14. Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M, et al. (2002) MINT: a Molecular INTeraction database. FEBS Lett 513: 135-140.
15. Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, et al. (2009) An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 6: 91-97.
16. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-1178.
17. Huang H, Jedynak BM, Bader JS, (2007) Where have all the interactions gone? Estimating the coverage of two-hybrid protein interaction maps. PLoS Comput Biol 3: e214.
18. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, et al. (2009) An empirical framework for binary interactome mapping. Nat Methods 6: 83-90.
19. Cassonnet P, Rolloy C, Neveu G, Vidalain PO, Chantier T, et al. (2011) Benchmarking a luciferase complementation assay for detecting protein complexes. Nat Methods 8: 990-992.
20. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, et al. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A 98: 4569-4574.
21. Sanchez IE, Dellarole M, Gaston K, de Prat Gay G, (2008) Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res 36: 756-769.
22. Gagnon D, Joubert S, Senechal H, Fradet-Turcotte A, Torre S, et al. (2009) Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J Virol 83: 4127-4139.
23. Hou SY, Wu SY, Chiang CM, (2002) Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding. J Biol Chem 277: 45619-45629.
24. Kovelman R, Bilter GK, Glezer E, Tsou AY, Barbosa MS, (1996) Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J Virol 70: 7549-7560.
25. Abbate EA, Voitenleitner C, Botchan MR, (2006) Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol Cell 24: 877-889.
26. Senechal H, Poirier GG, Coulombe B, Laimins LA, Archambault J, (2007) Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358: 10-17.
27. Haynes C, Oldfield CJ, Ji F, Klitgord N, Cusick ME, et al. (2006) Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput Biol 2: e100.
28. Zhang J, Kalkum M, Chait BT, Roeder RG, (2002) The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9: 611-623.
29. Calderwood MA, Venkatesan K, Xing L, Chase MR, Vazquez A, et al. (2007) Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci U S A 104: 7606-7611.
30. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, et al. (2008) Hepatitis C virus infection protein network. Mol Syst Biol 4: 230.
31. Dyer MD, Murali TM, Sobral BW, (2008) The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog 4: e32.
32. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
33. Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, et al. (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci U S A 107: 3752-3757.
34. Lamkanfi M, Dixit VM, (2010) Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8: 44-54.
35. Thierry F, Demeret C, (2008) Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins. Cell Death Differ 15: 1356-1363.
36. Lai MC, Teh BH, Tarn WY, (1999) A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J Biol Chem 274: 11832-11841.
37. Collier B, Goobar-Larsson L, Sokolowski M, Schwartz S, (1998) Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J Biol Chem 273: 22648-22656.
38. Bellanger S, Demeret C, Goyat S, Thierry F, (2001) Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J Virol 75: 7244-7251.
39. Zheng G, Schweiger MR, Martinez-Noel G, Zheng L, Smith JA, et al. (2009) Brd4 regulation of papillomavirus protein E2 stability. J Virol 83: 8683-8692.
40. Wang X, Naidu SR, Sverdrup F, Androphy EJ, (2009) Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J Virol 83: 2274-2284.
41. Letian T, Tianyu Z, (2010) Cellular receptor binding and entry of human papillomavirus. Virol J 7: 2.
42. Zhao KN, Hengst K, Liu WJ, Liu YH, Liu XS, et al. (2000) BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology 272: 382-393.
43. Buck CB, Pastrana DV, Lowy DR, Schiller JT, (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757.
44. Caplan S, Hartnell LM, Aguilar RC, Naslavsky N, Bonifacino JS, (2001) Human Vam6p promotes lysosome clustering and fusion in vivo. J Cell Biol 154: 109-122.
45. Perez-Victoria FJ, Mardones GA, Bonifacino JS, (2008) Requirement of the human GARP complex for mannose 6-phosphate-receptor-dependent sorting of cathepsin D to lysosomes. Mol Biol Cell 19: 2350-2362.
46. Lee SH, McCormick F, Saya H, (1069) Mad2 inhibits the mitotic kinesin MKlp2. J Cell Biol 191: 1069-1077.
47. Pellet J, Tafforeau L, Lucas-Hourani M, Navratil V, Meyniel L, et al. (2010) ViralORFeome: an integrated database to generate a versatile collection of viral ORFs. Nucleic Acids Res 38: D371-378.
48. Felsenstein J, (1989) PHYLIP- Phylogeny Inference Package (Version 3.2). Cladistics 5: 164-166.
49. Saldanha AJ, (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
50. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T, (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432.